Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
glycoprotein\; involved in neuronal cell-to-cell interaction [RGD, Feb 2006].. Additionally we are shipping CD200 Proteins (29) and CD200 Kits (19) and many more products for this protein.
Showing 10 out of 329 products:
Rat (Rattus) Monoclonal CD200 Primary Antibody for FACS - ABIN120528
Barclay, Ward: Purification and chemical characterisation of membrane glycoproteins from rat thymocytes and brain, recognised by monoclonal antibody MRC OX 2. in European journal of biochemistry / FEBS 1983
Show all 7 references for ABIN120528
Rat (Rattus) Monoclonal CD200 Primary Antibody for FACS - ABIN120526
Barclay: The localization of populations of lymphocytes defined by monoclonal antibodies in rat lymphoid tissues. in Immunology 1981
Show all 4 references for ABIN120526
Rat (Rattus) Monoclonal CD200 Primary Antibody for FACS - ABIN120529
Barclay: Different reticular elements in rat lymphoid tissue identified by localization of Ia, Thy-1 and MRC OX 2 antigens. in Immunology 1982
Show all 3 references for ABIN120529
Mouse (Murine) Monoclonal CD200 Primary Antibody for FACS - ABIN319963
Hoek, Ruuls, Murphy, Wright, Goddard, Zurawski, Blom, Homola, Streit, Brown, Barclay, Sedgwick: Down-regulation of the macrophage lineage through interaction with OX2 (CD200). in Science (New York, N.Y.) 2000
Show all 2 references for ABIN319963
Mouse (Murine) Monoclonal CD200 Primary Antibody for FACS - ABIN119279
Broderick, Hoek, Forrester, Liversidge, Sedgwick, Dick: Constitutive retinal CD200 expression regulates resident microglia and activation state of inflammatory cells during experimental autoimmune uveoretinitis. in The American journal of pathology 2002
Show all 2 references for ABIN119279
Mouse (Murine) Monoclonal CD200 Primary Antibody for FACS - ABIN319959
Nathan, Muller: Putting the brakes on innate immunity: a regulatory role for CD200? in Nature immunology 2001
Show all 2 references for ABIN319959
Human Polyclonal CD200 Primary Antibody for ELISA, WB - ABIN1997709
Minas, Liversidge: Is the CD200/CD200 receptor interaction more than just a myeloid cell inhibitory signal? in Critical reviews in immunology 2006
Human Monoclonal CD200 Primary Antibody for FACS - ABIN119290
Wright, Jones, Puklavec, Brown, Barclay: The unusual distribution of the neuronal/lymphoid cell surface CD200 (OX2) glycoprotein is conserved in humans. in Immunology 2001
Human Polyclonal CD200 Primary Antibody for IF (p), IHC (p) - ABIN761396
Clark, Arredondo, Dhesy-Thind: The CD200 tolerance-signaling molecule and its receptor, CD200R1, are expressed in human placental villus trophoblast and in peri-implant decidua by 5 weeks' gestation. in Journal of reproductive immunology 2015
Rat (Rattus) Monoclonal CD200 Primary Antibody for FACS, IHC (fro) - ABIN182015
McMaster, Williams: Identification of Ia glycoproteins in rat thymus and purification from rat spleen. in European journal of immunology 1980
The CD200:CD200R (show CD200R1 Antibodies) axis plays an immunoregulatory role in control of DSS (show PMP22 Antibodies) induced colitis in mice
Data show that neutrophil infiltration of tissues was markedly decreased in CD200 antigen (tg) transgenic animals and increased in CD200 receptor 1 CD200R1 (show CD200R1 Antibodies)(-/-) knockout mice.
we show a causal role for the CD200-CD200R (show CD200R1 Antibodies) inhibitory axis in arteriogenesis in a murine hindlimb ischemia model.
CD200 upregulation in reactive glial cells is modulated through PPAR-gamma (show PPARG Antibodies).
Anti-CD200R2 (show CD200R1L Antibodies), anti-IL-9 (show IL9 Antibodies), anti-IL-35, or anti-TGF-beta (show TGFB1 Antibodies) abolishes increased graft survival and Treg induction induced in cromolyn-treated CD200R1KO.CD200tg mice, and suggest combined role of mast cells and Tregs.
a role for both graft and host CD200/CD200R (show CD200R1 Antibodies) expression in increased allograft survival.
The main sites of CD200/CD200 receptor (CD200R (show CD200R1 Antibodies)) interaction in neonates and blood vessels, until adulthood, highlight the possible role of the CD200/CD200R (show CD200R1 Antibodies) system in microglial development and renewal.
CD200 may be expressed in the alternative activation of microglia and play a beneficial role in neuroinflammation.
a local (to the grafted tissue) tolerance mechanism initiated after CD200/CD200R (show CD200R1 Antibodies) engagement in primary graft recipients can lead to prolonged survival of grafts on transfer to secondary control nontransgenic recipients.
the increased CD200 expression by breast cancer cells (and/or host tissue) may be an important variable involved in determining the risk of metastasis.
CD200 expression by cultured cultured bone marrow mesenchymal stem cells can be induced by both osteogenic and pro-inflammatory cytokines through the sole NF-kappaB (show NFKB1 Antibodies) pathway.
suggest that microglial activation may be partially caused by CD47 (show CD47 Antibodies)/signal regulatory protein-alpha (show SIRPA Antibodies)- and CD200/CD200R (show CD200R1 Antibodies)-mediated reductions in the immune inhibitory pathways
CD200 is up-regulated and may be a novel biomarker for the prognosis in cutaneous squamous cell carcinoma.
CD200 expression is a useful marker for evaluation of the severity of PCM (show PCMT1 Antibodies) and that lack of CD200 expression may improve the sensitivity of PCM (show PCMT1 Antibodies) to therapy with new drugs.
the combination of CD200 and CD148 (show PTPRJ Antibodies) may have a potential differential diagnostic value in leukemic B-CLPDs, especially between CLL and MCL (show FH Antibodies).
CD200-CD200R1 (show CD200R1 Antibodies) signaling may be required for human pregnancy success.
CD200 signaling may play a key role in regulating macrophage polarization toward anti-inflammatory phenotypes
Suggest CD200 as both prognostic factor and potential therapeutic target AML (show RUNX1 Antibodies), aiming to reverse the "do not eat me" signal of CD200 or to manipulate the suppressive immune microenvironment induced by CD200 binding to its receptor.
CD160 (show CD160 Antibodies) and CD200 are expressed in B cells in chronic lymphocytic leukemia and are absent in other mature B-cell neoplasms.
our study confirms that CD200/BTLA (show BTLA Antibodies) deletions are recurrent genetic lesions in the biology of BCP (show OPN1SW Antibodies)-ALL
glycoprotein\; involved in neuronal cell-to-cell interaction
, CD200 antigen
, OX-2 membrane glycoprotein
, MRC OX-2 antigen
, antigen identified by monoclonal antibody MRC OX-2
, Cd200 antigen
, cell surface protein (thymocyte antigen identified by monoclonal antibody MRC-OX2)